Member Info for mitchoftheday

I think it must be a DM, pb.

EB - So what is the evidence that the FDA (and the MHRA come to that) do not "have a good track record" when it comes to devices that allegedly reduce medicine use? I'd be genuinely interested if there is any.

To your point gawdhelpus, NT for even 4000 shares at the mo

Posted on LinkedIn by BMN yesterday (short version):
A victory for SA’s vanadium sector!
We are delighted by the results released today by the US Department of Commerce on its investigation, under Section 232 of the Trade Expansion Act of 1962, into the effect of imports of vanadium on the national security of the United States.For Bushveld Minerals, the US is a critical market, especially as vanadium demand is expected to get a boost from the increasing demand for vanadium-based energy storage solutions globally.
This is a real victory not only for Bushveld Minerals, but for South Africa, which hosts large deposits of high-grade vanadium.

This is a good start!:
"A key part of the government’s approach to managing COVID-19 in the long term is to facilitate a thriving private sector market for COVID-19 detection tests to supplement and support testing led by NHS Test and Trace."

Where is that information from RMF?

@neutronic
It seems that suggests that there are different prodict design elements to move from professional to self testing, which presumably is whay thetest for not orginally submitted for both at the same time.

Don't think it's the real Innova account!
"We source the worlds most mediocre medical tech on Alibaba and sell it on for a big profit"

Also available via the 'Short positions' button at the top of this page :-)

In a nutshell:
Mahoosive UK govt funded research project into ovarian cancer just failed to find any better ways to detect it early.
AGL have tech to do this. Expect trial results and commecrial deployment in their labs in Q4.

Thanks fb. Very clear :)

..are thing, apparently. Apologies of if this is not new news, but I hadn't realised this technology was so advanced.
Given the explosion in demand for lithium from EV makers, it's more and more unlikely Li-ion batteries will find their way into many stationary storage applications. Standard Energy seem to be close to making a safer and more sustainable alternative.
https://tcrn.ch/3dZ1SX3
"Standard Energy has already performed a total of over one million battery testing hours, including in a lab, at a certified battery performance test site and in actual operations. Kim said the company is confident its performance data will convince customers to adopt vanadium ion batteries.

In a press statement, SoftBank Ventures Asia senior partner Daniel Kang said, “The existing ESS market was in a state of imbalance due to the rapidly growing demand, and safety and efficiency issues of products. Standard Energy is expected to create new standards for the global ESS market through its innovative material and design technology with massive manufacturing capabilities.”

Thanks BBN. It's a remarkable story, brilliantly dissected.
I'm not going to be taking Fortune on at chess any time soon!
PS I've just realised I made a mistake - the original shareholder in VRFB-H was BE, not BMN as I previously said. Not that it makes a lot of odds now.

There's more.
When VRFB Holdings Ltd was incorporated (in Guernsey on 3/12/20) the share ownership was 66% Borromeo's Acacia Resources and 33% BMN (not BE). So the obvious conclusion is that the remaining 27.4% of VRFB-H's shares (after accounting for Mustang's 22.1% and BE's 50.5% ) that we don't know about, belong to Acacia. Any changes to the shareholding have yet to be registered with the Guernsey Registry though.
Also, when Enerox Holdings Ltd (EHL) was incorporated the ownership was 50% BMN and 50% Garnet Commerce Ltd. Garnet Commerce is based in Alberta Canada and owned by one Dean Petersen, a HNW individual with a more than passing interest in Vanadium. At one point about 5 years ago he was a buyer of about $1.5m dollars' worth of Largo shares.
Finally, on December 10th 2020 Stephen L Prince, ex CEO of Younicos, and was appointed a director of EHL on December 10th, and to the Cellcube board at about the same time. He is so a special advisor at Alexa Capital, an international corp finance advisory firm with a focus on 'the energy transition'. It's not clear if his appointment is associated with another, as yet unknown, member of the consortium.

Good point Maen. Doxorubicin is also generic so sells for far less - about a fifth - of the price of patented medicines, which pro-doxorubicin will be. So that's a TAM of $5bn, without counting any greater demand as a result of reduced toxicity and higher effectiveness.

You'll find Alfa on twitter under BMNperspective. BBN also spends more time there now.

Wow! Fortune's gonna need a bigger... ...everything!

Sorry to disappoint you Chester but the contract is worth up to £875k. You got the dollar conversion backwards.

Ah. He's chairman of Duferco.

Very interesting maninshed. Anyone know who Bruno Bolfo is?